Atlas Trials

Cardiac Toxicity and Prognostic Value of New Echocardiographic Indicators in the Treatment of Primary Multiple Myeloma

Clinical trial NCT06039735 · RECRUITING

Trial details

NCT number
NCT06039735
Sponsor
Qilu Hospital of Shandong University
Status
RECRUITING
Study type
OBSERVATIONAL
Multiple Myeloma
Start date
2023-11-16
Primary completion
2023-11-16
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.